foxo4 dri senolytic peptide human trial 2024 2025

foxo4 dri senolytic peptide human trial 2024 2025 FOXO4-DRI UK | Research FOXO4-DRI 10mg vial - Description

Name: foxo4 dri senolytic peptide human trial 2024 2025 FOXO4-DRI UK | Research FOXO4-DRI 10mg vial - Description
Brand: metron-ms.com
SKU: 33820717765
Price: 25.80 USD
Availability: InStock
Rating: 4.4545 (28 reviews)

FOXO4 DRI 10mg vial Description RCpeptides Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Aging Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway

SKU: 33820717765 · From metron-ms.com

4.5

USD25.80 USD73.80

Pay in 4 interest-free payments of $6.45 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Every number on this page comes from animal research or community self-reports

GMP certified / 99% HPLC purity / Pan-India delivery / Cash on Delivery available Research Use Only This product is intended solely for laboratory and research purposes

The solution should develop a blue tint confirming copper chelation

Studies indicate that GHK-Cu may stimulate the production of collagen types I, III, and V, as well as elastin, decorin, and glycosaminoglycans in fibroblast cell cultures

The peptide also promotes polarization of macrophages from pro-inflammatory M1 phenotypes toward tissue-repairing M2 phenotypes, with treated macrophages showing 70% increased phagocytic activity for clearing inflammatory debris and 3-fold higher production of VEGF compared to untreated controls